FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Lipoprotein, Low Density, Removal

PMA: P940016 · Supplement: S022 · Decision Nov 15, 2016
Classifications
1
FEI Numbers
5
Registration Numbers
5

Basic Information

Device Name
Lipoprotein, Low Density, Removal
Trade Name
H.E.L.P. Futura Apheresis System
PMA Number
P940016
Supplement Number
S022
Device Class
FDA Class 3
Product Code
MMY
Generic Name
Lipoprotein, low density, removal
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
November 15, 2016
Date Received
October 17, 2016
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Substitution of the Transducer Protector present in the H.E.L.P lines with a new configuration.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MMY Lipoprotein, Low Density, Removal